Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
Nature Microbiology(2)
Cell(1)
Genome Announcements(1)
Nature Communications(1)
Wellcome Open Research(1)
Área temáticas
Enfermedades(5)
Medicina forense; incidencia de enfermedades(4)
Farmacología y terapéutica(1)
Origen
scopus(6)
First complete genome sequences of Zika virus isolated from febrile patient sera in Ecuador
ArticleAbstract: Here, we present the complete genome sequences of two Zika virus (ZIKV) strains, EcEs062_16 and EcEsPalabras claves:Autores:Bonsall D., Carroll M.W., Christopher H. Logue, Coloma J., Gabriel Trueba, J. Carrera, Joseph Neil Spindel Eisenberg, Klenerman P., Lewandowski K., Loman N.J., Paz V., Powell R., Pullan S.T., Pybus O.G., Quick J., Sully Márquez, Thézé J.Fuentes:scopusTwo doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
ArticleAbstract: The extent to which immune responses to natural infection with severe acute respiratory syndrome corPalabras claves:Autores:Abuelgasim H., Adele S., Adland E., Adlou S., Alhussni A., Ali M., Amini A., Barnes E., Blackwell L., Bridges-Webb A., Brown A., Brown H., Camara S., Carroll M.W., Cassar M.P., Chinnakannan S., Conlon C.P., Csala A., Cutteridge J., de Lara C., de Oliveira T., de Silva T.I., Deeks A.S., Denly L., Dimitriadis S., Dold C., Dong T., Donnison T., Dunachie S.J., Duncan C.J.A., Edmans M., Frater J., Fries A., Goulder P., Hackstein C.P., Harding A.C., Hill J., Ho L.P., Holmes J., Huang K.Y.A., Hutchings C.L., James W.S., Javier Gilbert Jaramillo, Jay C., Jeffery K., Johnson S.A., Kasanyinga M., Kerneis S., Klenerman P., Knight J.C., Knight M.L., Lee L.N., Li W., Lillie K., Linder A., Longet S., Malone T., Marinou S., Marjot T., Matthews P.C., Mehta H., Mentzer A.J., Moore S.C., Neubauer S., Ogbe A., O’Donnell D., Pace M., Payne R.P., Peng Y., Petousi N., Phalora P., Phillips E., Pollard A.J., Raman B., Richter A., Rijal P., Robinson N., Rongkard P., Schimanski L., Sigal A., Silva-Reyes L., Simmons B., Skelly D.T., Stafford L., Talbot N.P., Tan T.K., Thomas S.R., Tipoe T., Tipton T., Townsend A.R., Turtle L., Watson A.J.R., Weeks E., Wilson R., Zacharopoulou P.Fuentes:scopusSARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
ArticleAbstract: Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response toPalabras claves:Autores:Abraham P., Adams H., Adele S., Afifi S., Asamaphan P., Ash A., Ashraf S., Austin J.A., Azim Ansari M., Barnes E., Barrow M., Beckwith S.M., Beer R., Bernardo M. Gutierrez, Bonsall D., Bresner C., Brown A., Buchan S.L., Cantoni D., Connor T.R., Cowton V., Curran T., Cutino-Moguel T., da Silva Filipe A., Davis C., De Lorenzo G., de Silva T.I., Deeks A.S., Dunachie S.J., Duncan C.J.A., Edgeworth J., Fairley D.J., Fraser C., Fryer H., Fuller W., Furnon W., Golubchik T., Grove J., Guest M., Gunson R., Harvey W.T., Holden M.T.G., Holland P., Hughes J., John M., Jones O., Kele B., Kitchen C., Klenerman P., Koshy C., Kronsteiner B., Logan N., Lythgoe K., Mack A., MacLean O.A., Maksimovic J., Manali M., Mantzouratou A., Marchbank A., McCluggage K., McKenna J.P., Merrick I., Moore S.C., Morgan S., Morriss A., Munn R., Murcia P.R., Murray A., Murray S.M., Nebbia G., Orton R.J., Pascall D.J., Patel A., Patel A.H., Patel B., Payne R.P., Pinto R.M., Price A., Puxty K., Reynolds N., Richter A., Scott S., Shaaban S., Silva V., Singleton D., Smollett K., Southgate J., Spellman K., Szemiel A., Templeton K.E., Thomson L., Tong L., Turtle L., Vink E., Warne B., Whalley T., Wilkie C., Willett B.J., Workman T., Yebra G.Fuentes:scopusSARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus
ArticleAbstract: Background: Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses PCR to detectPalabras claves:Biomarker, Blood, covid-19, Laboratory safety, RNA, SARS-COV-2, Viraemia, Viral loadAutores:Andersson M.I., Arancibia-Cárcamo C.V., Auckland K., Baillie J.K., Barnes E., Beneke T., Bibi S., Brooks T.J.G., Carroll M.W., Crook D.W., Dingle K., Dold C., Downs L.O., Dunn L., Eyre D.W., Harvala H., Hoosdally S., Ijaz S., James T., James W.S., Javier Gilbert Jaramillo, Jeffery K., Justice A., Klenerman P., Knight J.C., Knight M.L., Liu X., Lumley S.F., Matthews P.C., McNaughton A.L., Mentzer A.J., Mongkolsapaya J., Oakley S., Oliveira M.S., Peto T., Ploeg R.J., Ratcliff J., Robbins M.J., Roberts D.J., Rudkin J., Russell R.A., Screaton G.R., Semple M.G., Simmonds P., Skelly D.T., Stoesser N., Turtle L., Wareing S., Zambon M.Fuentes:scopusPublisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (Nature Microbiology, (2022), 7, 8, (1161-1179), 10.1038/s41564-022-01143-7)
OtherAbstract: In the version of this article initially published, the author affiliation information was incompletPalabras claves:Autores:Abraham P., Adams H., Adele S., Afifi S., Asamaphan P., Ash A., Ashraf S., Austin J.A., Azim Ansari M., Barnes E., Barrow M., Beckwith S.M., Beer R., Bernardo M. Gutierrez, Bonsall D., Bresner C., Brown A., Buchan S.L., Cantoni D., Connor T.R., Cowton V., Curran T., Cutino-Moguel T., da Silva Filipe A., Davis C., De Lorenzo G., de Silva T., Deeks A.S., Dunachie S., Dunachie S.J., Duncan C.J.A., Fairley D.J., Fraser C., Fryer H., Fuller W., Furnon W., Golubchik T., Grove J., Guest M., Gunson R.N., Harvey W.T., Holden M.T.G., Holland P., Hughes J., John M., Jones O., Kele B., Kitchen C., Klenerman P., Koshy C., Kronsteiner B., Logan N., Lythgoe K., Mack A., MacLean O.A., Maksimovic J., Manali M., Mantzouratou A., Marchbank A., McCluggage K., McKenna J.P., Merrick I., Moore S.C., Morgan S., Morriss A., Munn R., Murcia P.R., Murray A., Murray S.M., Nebbia G., Orton R.J., Pascall D.J., Patel A., Patel A.H., Patel B., Payne R.P., Pinto R.M., Price A., Puxty K., Reynolds N., Richter A., Scott S., Shaaban S., Silva V., Singleton D., Smollett K., Southgate J., Spellman K., Szemiel A., Templeton K., Thomson L., Tong L., Turtle L., Vink E., Warne B., Whalley T., Wilkie C., Willett B.J., Workman T., Yebra G.Fuentes:scopusThe antigenic anatomy of SARS-CoV-2 receptor binding domain
ArticleAbstract: Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency use as therapPalabras claves:coronavirus, SARS-CoV-2, anti-RBD antibody, receptor binding domain, antibody, immune responses, virus structureAutores:Bailey A.L., Bertram F.K.R., Bolton J., Carroll M.W., Case J.B., Chen R.E., Clare D.K., Dejnirattisai W., Diamond M.S., Dold C., Dong T., Duyvesteyn H.M.E., Fry E.E., Fyfe A., Ginn H.M., Gupta S., Hall D.R., Howe A., Huang K.Y.A., James W.S., Javier Gilbert Jaramillo, Kafai N.M., Klenerman P., Knight J.C., Knight M.L., Levin R., Liu C., López-Camacho C., Mentzer A.J., Mongkolsapaya J., Paesen G.C., Paterson N.G., Peng Y., Pollard A.J., Radecke J., Ren J., Screaton G.R., Siebert C.A., Skelly D.T., Slon-Campos J., Song Y., Stuart D.I., Supasa P., Tan T.K., Temperton N.J., Thompson C., Townsend A.R., Walter T.S., Wang B., Williams M.A., Ying B., Zhao Y., Zhou D.Fuentes:scopus